The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients

L. M. van Roozendaal*, R. J. Schipper, K. K. B. T. Van de Vijver, C. M. Haekens, M. B. I. Lobbes, V. C. G. Tjan-Heijnen, M. de Boer, M. L. Smidt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)469-476
Number of pages8
JournalBreast Cancer Research and Treatment
Volume143
Issue number3
DOIs
Publication statusPublished - Feb 2014

Keywords

  • Breast neoplasms
  • Nodal staging
  • Axillary ultrasound
  • Sentinel lymph node biopsy
  • Pathological lymph node status
  • Adjuvant systemic treatment
  • SURVIVAL
  • METASTASES
  • BIOPSY
  • MICROMETASTASES
  • RATIO
  • SENTINEL-NODE
  • AXILLARY DISSECTION
  • TRIAL
  • WOMEN
  • ULTRASOUND

Cite this